Overview

Exoskeleton Market is poised to value over USD 4.1 billion by 2027 end at a CAGR of over 45% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides a comprehensive analysis of Exoskeleton Market trends that influence the overall market growth. Furthermore, it includes elaborative insights on the graph of profitability, SWOT analysis, market share and regional business growth. Moreover, the report offers apprehension on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Exoskeleton Market is predicted to achieve substantial growth by the end of the forecast period. The report explains that this business is anticipated to record a noteworthy growth rate over the forecasted timeframe. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also includes a thorough list of market segmentations along with the growth opportunities across this business vertical.

Major players included in the Exoskeleton Market:
• ReWalk Robotics Ltd.
• Ekso Bionics
• Rex Bionics Plc
• Suit X (U.S. Bionics Inc.)
• Lockheed Martin Corporation
• Hocoma
• Parker Hannifin Corporation
• Hyundai Motor Company
• Axiobionics
• Myomo, Inc.
• Honda Motor Co. Ltd.
• Technaid. S.L.
• Gogoa Mobility Robots SL
• Wearable Robotics SRL
• DIH Technologies Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)

Exoskeleton Market Segmentation:
By Component
• Hardware
  o Sensor
  o Actuator
  o Power Source
  o Control System/Controller
  o Others (Body Material and other Electronic, Electrical, and Mechanical Components)
• Software

By Type
• Powered
• Passive

By Mobility
• Stationary
• Mobile

By Body Part
• Lower Extremities
• Upper Extremities
• Full Body

By Vertical
• Healthcare
• Defense
• Industrial
• Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness)

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Exoskeleton Market By Component,By Type,By Mobility,By Body Part,By Vertical and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions

Flexible Model:
• We have a flexible Model and you can suggest changes in the scope/table of content as per your requirement
• The customisations offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Exoskeleton Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Type Of Administration Overview
  4.6. Dermatology Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Exoskeleton Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Dermatology Framework

6. Global Exoskeleton Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Drive Type Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Drive Type Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Exoskeleton Market, By Component Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Hardware
       7.1.1. Sensor
       7.1.2. Actuator
       7.1.3. Power Source
       7.1.4. Control System/Controller
       7.1.5. Others (Body Material and other Electronic, Electrical, and Mechanical Components)
  7.2. Software

8. Global Exoskeleton Market,By Type Historical Analysis and Forecast 2020-2027 (USD Million)
   8.1. Powered
   8.2. Passive
  
9. Global Exoskeleton Market,By Mobility Historical Analysis and Forecast 2020-2027 (USD Million)
   9.1. Stationary
   9.2. Mobile
  
10. Global Exoskeleton Market, By Body Part Historical Analysis and Forecast 2020-2027 (USD Million)
    10.1. Lower Extremities
    10.2. Upper Extremities
    10.3. Full Body

11. Global Exoskeleton Market, By Vertical Historical Analysis and Forecast 2020-2027 (USD Million)
    11.1. Healthcare
    11.2. Defense
    11.3. Industrial
    11.4. Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness) 

12. North America Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  12.1. Introduction
  12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       12.2.1. U.S.A
       12.2.2. Canada
       12.2.3. Mexico
  12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2020-2027

15. Asia Pacific Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         16.2.1. Saudi Arabia
         16.2.2. UAE
         16.2.3. South Africa
         16.2.4. Egypt
   16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4.  North America - Market Share Analysis and Key Regional Players
   17.5.  Europe - Market Share Analysis and Key Regional Players
   17.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   17.7.  Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts)
   18.1. ReWalk Robotics Ltd.
         18.1.1. Company Overview
         18.1.2. Type Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. Ekso Bionics
         18.2.1. Company Overview
         18.2.2. Type Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. Rex Bionics Plc
         18.3.1. Company Overview
         18.3.2. Type Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. Suit X (U.S. Bionics Inc.)
         18.4.2. Type Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5. Lockheed Martin Corporation
         18.5.1. Company Overview
         18.5.2. Type Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6. Hocoma
         18.6.1. Company Overview
         18.6.2. Type Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. Parker Hannifin Corporation
         18.7.1. Company Overview
         18.7.2. Type Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. Hyundai Motor Company
         18.8.1. Company Overview
         18.8.2. Type Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. Axiobionics
         18.9.1. Company Overview
         18.9.2. Type Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10. Myomo, Inc.  
         18.10.1. Company Overview
         18.10.2. Type Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11. Honda Motor Co. Ltd.
         18.11.1. Company Overview
         18.11.2. Type Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview
   18.12. Technaid. S.L.
         18.12.1. Company Overview
         18.12.2. Type Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13. Gogoa Mobility Robots SL
         18.13.1. Company Overview
         18.13.2. Type Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14. Wearable Robotics SRL
         18.14.1. Company Overview
         18.14.2. Type Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   18.15. DIH Technologies Corporation
         18.15.1. Company Overview
         18.15.2. Type Portfolio
         18.15.3. SWOT Analysis
         18.15.4. Financial Overview
         18.15.5. Strategic Overview

19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures